Add-on Acquisition • Life Science

Colossal Acquires Viagen Pets

On November 4, 2025, Colossal acquired life science company Viagen Pets

Acquisition Context

This is Colossal’s 1st transaction in the Life Science sector.
This is Colossal’s 1st transaction in the United States.
This is Colossal’s 1st transaction in Texas.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	November 4, 2025
Target	Viagen Pets
Sector	Life Science
Buyer(s)	Colossal
Deal Type	Add-on Acquisition

Target Company

Viagen Pets

Cedar Park, Texas, United States

Viagen Pets provides animal genetic preservation and cloning services for companion animals and horses. Viagen Pets’ offerings include tissue banking, DNA storage, and cloning procedures for dogs, cats, and equines, as well as conservation programs for endangered species. Viagen Pets was founded in 2002 and is headquartered in Cedar Park, Texas.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Colossal

Austin, Texas, United States

Category	Company
Founded	2021
Sector	Life Science

DESCRIPTION

Colossal is a biotechnology and genetic-engineering company focused on using genome editing and reproductive technologies to restore extinct species and strengthen conservation of critically endangered animals. Colossal was founded in 2021 and is headquartered in Dallas, Texas.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Texas	1 of 1
Country: United States	1 of 1
Year: 2025	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Texas M&A - United States M&A - 2025 M&A